Stocks / Pharmaceuticals

DYNPharmaceuticals

Dyne Therapeutics, Inc.
$17.861d -6.8%5d -29.1%settled close · 2026-09-10
Mkt cap $2.9B (9/8)β 2.1352w $12.37–27Shares 165.0MInd. Pharmaceutical PreparationsNasdaq since 2020Emp. 258HQ Waltham, MAdyne-tx.com
Who’s talkingIdea Scout · free

Who’s talking about DYN

No tracked investor commentary on DYN yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 2 Nov 2026

Confirmed date · consensus EPS -0.90. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where DYN’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 25 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-08
2026-09-03
2026-08-28
2026-08-27
2026-08-25
2026-08-24
2026-08-21
2026-08-17
2026-08-12
2026-08-11
2026-08-10
2026-07-23
2026-07-14
2026-07-09
2026-07-07
2026-04-28
2026-04-23
2026-04-22
2026-04-21
2026-04-20
2026-04-17
2026-04-16
2026-04-15
2026-04-14
2026-03-25
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on DYN is in this morning’s Brief. Get The Brief — $20/mo →